dapagliflozin
Sponsor AZN · listed as AZN
READOUT
Phase 3
Confidence: medium
Source: clinicaltrials
Next catalyst
Event typeREADOUT
Expected date2027-07-31
As disclosedJul 2027
Date precisionmonth
Confidencemedium
Trial & sponsor
Trial (NCT)NCT05374291
PhasePHASE3
StatusENROLLING_BY_INVITATION
Lead sponsorUniversity Medical Center Groningen
Listed asAZN
Condition(s)Kidney Disease, Chronic; Renal Transplant Failure; Heart Failure; Kidney Failure; Death
!
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.
Get the full dataset — $499 → More AZN catalysts